Coronavirus: EU reserves 300 mln doses of potential Sanofi COVID-19 vaccine

The logo of Sanofi is seen at the company's research and production centre in Vitry-sur-Seine. (Reuters)

The EU announced on Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.

The European Commission, the bloc’s executive arm which negotiated the agreement, said it would allow all 27 member countries to purchase the vaccine once it was proven to be safe and effective.

For more coronavirus news, visit our dedicated page.

In a related development, the US government will pay $2.1 billion to Sanofi and GlaxoSmithKline for COVID-19 vaccines to cover 50 million people and to underwrite the drug makers’ testing and manufacturing, the companies said on Friday.

For all the latest headlines follow our Google News channel online or via the app.

Read more:

Coronavirus: Chinese-backed hackers targeted COVID-19 vaccine firm Moderna

Children under five carry 10-100 higher levels of coronavirus in their noses: Study

SHOW MORE
Last Update: Friday, 31 July 2020 KSA 19:40 - GMT 16:40
Top